BRIEF-Harmony Biosciences Q1 Net Income USD 32.488 Million

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc.

HRMY

0.00

May 07 (Reuters) - Harmony Biosciences Q1 product revenue USD 215.387 million vs. IBES estimate USD 225.2 million.

  • Q1 operating income USD 37.291 million
  • Q1 pretax profit USD 39.687 million vs. IBES estimate USD 58.2 million
  • Q1 gross profit USD 170.875 million
This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.